Amsterdam University Medical Centers (Amsterdam UMC) / Amsterdam Universitair Medische Centra

VPS18 contributes to phagosome membrane integrity in Mycobacterium tuberculosis–infected macrophages (2025) Jani C, Jain N, Marsh AK, Uchil P, Doan T, Hudspith M, Glover OT, et al. Journal article The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey (2025) Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, et al. Journal article Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications (2025) León-Jiménez D, Sridhar VS, López-Mendoza M, Scholtes RA, Schmieder R, Cherney DZ, van Raalte DH, et al. Journal article, Review article Volatile anesthetics for lung- and diaphragm-protective sedation (2024) Müller-Wirtz LM, O’Gara B, Gama de Abreu M, Schultz MJ, Beitler JR, Jerath A, Meiser A Journal article, Review article Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years (2024) Berning P, Fekom M, Ngoya M, Goldstone AH, Dreger P, Montoto S, Finel H, et al. Journal article Young-GRAPPA 2023: The Future Is Bright (2024) Johnsson HJ, Ayan G, Coras R, Grynszpan R, Herrera S, Jethwa H, Silva DL, et al. Journal article Dominant CST3 variants cause adult onset leukodystrophy without amyloid angiopathy (2024) Bergner CG, Breur M, Soto-Bernardini MC, Schäfer L, Lier J, Le Duc D, Bundalian L, et al. Journal article Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire (2024) Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article